Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of November 28, 2012
  • Print
  • Share
  • E-mail
-
Back to Previous Page

Product Detail

Product Description Source Plasma
Recall Number B-0356-13
Classification Class II
Code Info 706368653; 8910006160; 8910005703; 891004620; 891003971; 8910003354; 8910002601; 8910001907; 8910001428; 8910000658; 8910000058; 7060239477; 7060238870; 7060235693; 7060235343; 7060233737; 7060232841; 7060232527; 7060230676; 7060230508; 7060229117; 7060228623; 7060227644; 7060227269; 7060226330; 7060225860; 7060224951; 7060224579; 7060223952; 7060223407; 7060222382; 7060221936; 7060213791; 7060213434; 7060211929; 7060211221; 7060210664; 7060209842; 7060209180; 7060208408; 7060207256; 7060206774; 7060205914; 7060205391; 7060368156
Product Distributed Qty 45 units
Reason For Recall Blood products, collected from a donor whose suitability was not adequately determined, were distributed.

Event Detail

Event Id 56198
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma, Inc.
City San Antonio
State TX
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2010-05-26
Initial Firm Notification of Consignee or Public FAX
Distribution Pattern NC, IN
-
-